| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 06/04/2009 | US20090143328 Method of Treating Cancer by Administration of Topical Active Corticosteroids |
| 06/04/2009 | US20090143320 Kinase suppressor of Ras inactivation for therapy of Ras mediated tumorigenesis |
| 06/04/2009 | US20090143319 Transcription factor decoy |
| 06/04/2009 | US20090143303 Anti-invasive and anti-angiogenic compositions |
| 06/04/2009 | US20090143280 Anti-cancer combination treatment and kit-of-parts |
| 06/04/2009 | US20090143275 Adiponectin receptor fragments and methods of use |
| 06/04/2009 | US20090142841 Vectors capable of immortalizing non-dividing cells and cells immortalized with said vectors |
| 06/04/2009 | US20090142782 Using actinobacillus specific immunogolbulins to diagnose gum disease |
| 06/04/2009 | US20090142427 Composition and its Therapeutic Use |
| 06/04/2009 | US20090142421 Active fraction of a polar solvent extract from the latex of euphorbiaceae plants |
| 06/04/2009 | US20090142413 Targeted short-lived drug delivery |
| 06/04/2009 | US20090142359 Anti-Her2 antibodies which induce apoptosis in Her2 expressing cells; treating cancer by Her2 overexpression using the antibodies |
| 06/04/2009 | US20090142358 Human antibodies specific to kdr and uses thereof |
| 06/04/2009 | US20090142349 CD19 Antibodies And Their uses |
| 06/04/2009 | US20090142345 Prophylactic/therapeutic agent for cancer |
| 06/04/2009 | US20090142334 DETECTION AND MODULATION OF IAPs AND NAIP FOR THE DIAGNOSIS AND TREATMENT OF PROLIFERATIVE DISEASE |
| 06/04/2009 | US20090142333 Activin-actriia antagonists and uses for promoting bone growth in cancer patients |
| 06/04/2009 | US20090142330 Use of inactive-plasmin to treat chronic inflammatory disease and tumors |
| 06/04/2009 | US20090142325 Compositions and methods for treating tumour spreading |
| 06/04/2009 | US20090142323 Methods for treating a disorder by regulating gprc6a |
| 06/04/2009 | US20090142316 Use of Dendrimers to Stimulate Cell Growth |
| 06/04/2009 | US20090142302 Insulin-like growth factor binding protein 7 for treatment of cancer |
| 06/04/2009 | US20090142301 Novel pharmaceutical composition of interferon gamma or pirfenidone with molecular diagnostics for the improved treatment of interstitial lung diseases |
| 06/04/2009 | US20090142296 Method of increasing trafficking of endothelial progenitor cells to ischemia-damaged tissue |
| 06/04/2009 | US20090142259 Compositions and methods for the diagnosis and treatment of bladder and urinary tract tumors |
| 06/04/2009 | CA2802984A1 Use of eph-b4 and ephrin-a1 for predicting negative physiological response to the treatment with erythropoietin |
| 06/04/2009 | CA2707009A1 Methods for inhibiting fascin |
| 06/04/2009 | CA2706946A1 2-fluoropyrazolo[1,5-a]pyrimidines as protein kinase inhibitors |
| 06/04/2009 | CA2706835A1 Stat3 epitope peptides |
| 06/04/2009 | CA2706750A1 Amplification of cancer-specific oncolytic viral infection by histone deacetylase inhibitors |
| 06/04/2009 | CA2706675A1 Amino acid sequences directed against her2 and polypeptides comprising the same for the treatment of cancers and/or tumors |
| 06/04/2009 | CA2706656A1 Compositions and methods for inhibiting the activation of dsrna-dependent protein kinase and tumor growth inhibition |
| 06/04/2009 | CA2706633A1 Novel cancer-associated antibody and antigen |
| 06/04/2009 | CA2706597A1 Targeted radiotherapy |
| 06/04/2009 | CA2706583A1 Inhibition of macrophage-stimulating protein receptor (ron) and methods of treatment thereof |
| 06/04/2009 | CA2706430A1 Polymorphs of a c-met/hgfr inhibitor |
| 06/04/2009 | CA2706419A1 Antigen-binding constructs |
| 06/04/2009 | CA2705977A1 Use of somatostatin analogs in meningioma |
| 06/04/2009 | CA2705906A1 Imidazo-thiazole derivatives as protein kinase inhibitors |
| 06/03/2009 | EP2065401A2 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
| 06/03/2009 | EP2065400A2 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
| 06/03/2009 | EP2065388A1 Pyrazolopyrimidine derivative |
| 06/03/2009 | EP2065384A1 Tricyclic thrombin receptor antagonist |
| 06/03/2009 | EP2065380A1 Pyridoneamide derivatives as focal adhesion kinase (FAK) inhibitors and their use for the treatment of cancer |
| 06/03/2009 | EP2065372A1 Antitumor agent for undifferentiated gastric cancer |
| 06/03/2009 | EP2065368A1 Inhibitors of IAP |
| 06/03/2009 | EP2065366A2 HIF hydroxylase inhibitors |
| 06/03/2009 | EP2065358A1 The prepartion and the use of ethoxy combretastatins and their prodrugs |
| 06/03/2009 | EP2065056A1 Hydrophilic matrix having poorly water-soluble compound sealed therein, and method for producing the same |
| 06/03/2009 | EP2065054A1 Combinations comprising a prostaglandin and uses thereof |
| 06/03/2009 | EP2065053A1 Cell death inhibitor |
| 06/03/2009 | EP2065050A1 Methods of treating multiple myeloma and myeloma-induced bone resorption using integrin antagonists |
| 06/03/2009 | EP2064951A1 Use of a substituted imidazole, derivatives or salts thereof for the preparation of a medicament for the treatment of a cell proliferative disorder |
| 06/03/2009 | EP2064239A2 Anti-activin a antibodies and uses thereof |
| 06/03/2009 | EP2064229A2 Oncolytic rhabdovirus |
| 06/03/2009 | EP2064214A1 Pyraz0l0(l,5-a) (1, 3, 5) triazine and pyrazolo (1, 5-a) pyrimidine derivatives useful as protein kinase inhibitors |
| 06/03/2009 | EP2064213A1 Heteroaryl derivatives as protein kinase inhibitors |
| 06/03/2009 | EP2064211A1 IMIDAZO[1,2-a]PYRIDINE HYDROXYMATE COMPOUNDS THAT ARE INHIBITORS OF HISTONE DEACETYLASE |
| 06/03/2009 | EP2064207A2 N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase |
| 06/03/2009 | EP2064203A1 2-benzimidaz0lyl-6-m0rph0lin0-4-piperidin-4-ylpyrimidine derivatives as pi3k and mtor inhibitors for the treatment of proliferative disorders |
| 06/03/2009 | EP2064200A1 Derivatives of 2-phenyl-3-hydroxyquinoline-4(1h)-one and methods of their preparation and utilization |
| 06/03/2009 | EP2064194A2 N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase |
| 06/03/2009 | EP2064189A2 Polymorphic form of 4-[3-(4-cyclopropanecarbonyl-piperazine-1-carbonyl)-4-fluoro-benzyl]-2h-phthalazin-1-one |
| 06/03/2009 | EP2063963A2 Methods for treating cancer comprising the administration of a vitamin d compound and an additional therapeutic agent |
| 06/03/2009 | EP2063917A1 Aptamers labelled with gallium-68 |
| 06/03/2009 | EP2063909A1 Formulations for therapeutic administration of thyroid stimulating hormone (tsh) |
| 06/03/2009 | EP2063900A1 A cancer sensitizer comprising glucosamine, glucosamine derivatives or salts thereof |
| 06/03/2009 | EP2063895A2 Combination drug |
| 06/03/2009 | EP2063887A2 New small molecule inhibitors of mdm2 and the uses thereof |
| 06/03/2009 | EP2063884A1 Pro-oxidant anti-cancer compounds |
| 06/03/2009 | EP2063879A2 Compositions of chk1 inhibitors and cyclodextrin |
| 06/03/2009 | EP2063878A2 Bis(thiohydrazide amides) for use in preventing or delaying the recurrence of melanoma |
| 06/03/2009 | EP1758904B1 Flavopereirine derivatives for cancer therapy |
| 06/03/2009 | EP1682546B1 Peptidomimetic compounds, stereoselective process for their preparation, their use as biologically active synthetic intermediates |
| 06/03/2009 | EP1608656B1 Imidazotriazine compounds for the treatment of cancer diseases |
| 06/03/2009 | EP1399440B1 5-(2-aminopyrimidin-4-yl)benzisoxazoles as protein kinase inhibitors |
| 06/03/2009 | EP1313737B1 Novel guanidino derivatives as inhibitors of cell adhesion |
| 06/03/2009 | EP1307454B1 Derivatives of variolin b |
| 06/03/2009 | EP1263720B1 Azetidine derivatives, preparation thereof and pharmaceutical compositions containing same |
| 06/03/2009 | EP1218544B1 TAR RNA binding peptides |
| 06/03/2009 | EP1165553B1 C10 ester substituted taxanes as antitumor agents |
| 06/03/2009 | EP1131426B1 Mage-10 or mage-8 derived hla-a2.1-binding oligopeptides |
| 06/03/2009 | EP1111054B1 A new gene of human lysoenzyme, the encoding polypeptide and methods for preparing them |
| 06/03/2009 | EP1071668B1 5-aminoindeno[1,2-c]pyrazol-4-ones as anti-cancer and anti-proliferative agents |
| 06/03/2009 | EP1012283B1 Mage-3 peptides presented by hla class ii molecules |
| 06/03/2009 | CN101446590A Methods for the identification of polypeptide antigens |
| 06/03/2009 | CN101445555A Antibodies to non-functional p2x7receptor, diagnosis and treatment of cancers and other conditions |
| 06/03/2009 | CN101445504A Dioxane-2-alkyl carbamates derivatives |
| 06/03/2009 | CN101445494A Conjugated psychotropic drugs and uses thereof |
| 06/03/2009 | CN101444624A Medicine for cancer therapy |
| 06/03/2009 | CN101444509A Triple monoamine reuptake inhibitors for the treatment of chronic pain |
| 06/03/2009 | CN101444476A New microsphere and method for producing the same |
| 06/03/2009 | CN100495028C A process for the isolation of a major harmful oxidant from cigarette smoke |
| 06/03/2009 | CN100494398C Method of determining glutachione-S-transferase pi expression |
| 06/03/2009 | CN100494388C Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (MVA) |
| 06/03/2009 | CN100494212C Indolopyrrolocabazole derivative and antitumor agent |
| 06/03/2009 | CN100494182C Regulatory factor of tumor necrosis alpha factor |
| 06/03/2009 | CN100493614C Anticancer medicine-chitosan complex for forming self-aggregates and preparation method thereof |
| 06/03/2009 | CN100493609C Medicine composition for treating malignant tumours and application |
| 06/03/2009 | CN100493586C Oral liquid for treating breast cancer, liver cancer or lung caner, and preparation thereof |